From the Liver Imaging Group (K.J.F., M.S.M., D.B., W.C.H., C.B.S.) and Department of Hepatology (R.L.), University of California-San Diego, 6206 Lakewood St, San Diego, CA 92122; Department of Radiology, Mayo Clinic, Rochester, Minn (S.K.V., J.C., K.P., J.M., K.J.B., R.E.); Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio (N.O.); Pfizer Research and Development, Pfizer, Inc, Sacramento, Calif (S.S.S.); Foundation for the National Institutes of Health, North Bethesda, Md (T.N.K., A.P.); Regeneron Pharmaceuticals, Inc, Tarrytown, NY (R.A.C.); Department of Gastroenterology, Virginia Commonwealth University, Richmond, Va (A.J.S.); Department of Radiology, Massachusetts General Hospital, Boston, Mass (A.E.S.); and Department of Imaging Alliances, Pfizer, Inc, New York, NY (S.P.S.).